Le Lézard
Classified in: Health, Science and technology, Business
Subject: PDT

Comau Launches MATE - A Compact, Lightweight Wearable Exoskeleton Fit for Workers


TURIN, Italy, September 26, 2018 /PRNewswire/ --

Comau, the global leader in advanced industrial automation solutions, launches MATE, its first innovative wearable exoskeleton. MATE has been designed to improve work quality in an efficient and highly ergonomic manner by providing consistent and advanced movement assistance during repetitive as well as daily tasks.

     (Photo: https://mma.prnewswire.com/media/749751/Comau__MATE.jpg )

The MATE Fit for Workers exoskeleton uses an advanced spring-based passive structure. MATE delivers lightweight, breathable and highly effective postural support without the need for batteries, motors or other failure-prone devices. It is also compact and ergonomically designed thanks to the partnership between Comau, ÖSSUR, a leading non-invasive orthopedics company and IUVO, a spin-off company of The BioRobotics Institute (Scuola Superiore Sant'Anna) specialized in wearable technologies. MATE is fully able to replicate any movement of the shoulder while adhering to the body like a "second skin".

Maurizio Cremonini, Comau Head of Marketing, commented, "We are particularly proud to have developed this innovative wearable technology. MATE has been designed in close collaboration with factory workers, thus responding directly to their specific needs. With our exoskeleton, they will be able to do the same tasks but with less fatigue. For Comau, this is also an extraordinary opportunity to reach a global market that, according to the IFR, grew more than 60% from 2015 to 2017 and is estimated to continue growing at a rate of 25% each year until 2020. We believe that the industrial sector will represent about one third of the exoskeleton's applications." 

Reflecting Comau's vision and commitment to innovative, open and easy-to-use technologies, MATE is an important part in the company's HUMANufacturing Technology strategy, a concept in which people are protagonists within the smart factory together with cutting-edge, digital tools, enabling technologies and 'intelligent' industrial robotics within a networked production system. It is also the first of a series of wearable robotics that Comau is developing and commercializing in partnership with IUVO and Össur. A fundamental aspect of the collaboration is the joint desire to progress and evolve human-machine collaboration within diverse sectors, including biomedical, manufacturing and consumer. MATE was designed and developed at the Comau HUMANufacturing Innovation Center in Pontedera (Pisa), Italy.

Features 

Benefits 


These press releases may also interest you

at 09:50
Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 Phase 1/2 clinical trial in Spinal Muscular Atrophy (SMA) Type I at the American...

at 09:47
BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human...

at 09:45
Pleio, Inc. and FountainRx announce their partnership to provide a concierge-level experience to specialty pharmacy patients. The two companies are launching a program to provide patients with human-driven support as they onboard onto their specialty...

at 09:45
JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today released a Virtual Investor "What This Means" segment featuring Moleculin Biotech , a clinical stage pharmaceutical company with a...

at 09:41
Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Dengue antiviral' in...

at 09:35
Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively. CancerVision and...



News published on and distributed by: